Irfan Asangani was recently awarded a Department of Defense Idea Expansion Award (2021-2024) for his proposal entitled “PP2A activation as a therapy for AR addicted refractory castration-resistant prostate cancer.” Congratulations Irfan!
Irfan Asangani was recently awarded a Department of Defense Idea Expansion Award (2021-2024) for his proposal entitled “PP2A activation as a therapy for AR addicted refractory castration-resistant prostate cancer.” Congratulations Irfan!